Carlos Monteiro

Carlos Monteiro serves as CEO at Biojam Holding Group. Biojam Holding Group operates in the pharmaceuticals sector with approximately 12.0 employees. The company is headquartered in Lisbon, Lisbon.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 748 executive contacts are available in Lisbon.
• • Our database includes 201,468 c suite-level executives.

Outlook Microsoft Office 365 Nginx Woo Commerce Google Maps (Non Paid Users) Google Font API YouTube WordPress.org Google Maps reCAPTCHA Mobile Friendly

pharmaceutical manufacturing pharmaceutical acute lymphoblastic leukemia oncology transplantation pharmacovigilance scholarships medical innovation clinical research drug safety medical ethics nutritional supplements biomedical healthcare solutions patient care medical devices biotechnology healthcare funding children's cancer medical education hospital pharmacy medical community support social responsibility disease treatment healthcare logistics clinical trials medical consultation research grants medical policies adverse reactions medical professionals community healthcare drug administration electrolyte solutions ischemia protection clinical pharmaceuticals therapeutic solutions cancer treatments safety information medical training conventional medications pediatric oncology healthcare partnerships quality healthcare patient outcomes healthcare equity medical protocols academic collaboration precision medicine ethical standards pharmaceuticals medical hospital & health care health care health wellness & fitness

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Carlos Monteiro in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Biojam Holding Group.

Carlos Monteiro's Position in the MessageCEO Database

• •Carlos Monteiro is 1 of 1 verified executive contact we track at Biojam Holding Group.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •738 verified executive contacts in Lisbon are in the database.
• •1 verified contacts work at pharmaceuticals companies in the 12.0 employee range (same size as Biojam Holding Group).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Carlos Monteiro directly?

Carlos Monteiro's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Biojam Holding Group. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Carlos Monteiro work for?

Carlos Monteiro is CEO at Biojam Holding Group, a company in the pharmaceuticals sector with 12.0 employees. The company is based in Lisbon, Lisbon.

Can I pitch or sell to Carlos Monteiro?

As CEO at Biojam Holding Group, Carlos Monteiro is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Carlos Monteiro directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Carlos Monteiro in?

Carlos Monteiro works in the pharmaceuticals industry as CEO at Biojam Holding Group. MessageCEO provides verified contact information for executives across all major industries.

Is Carlos Monteiro's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Carlos Monteiro's profile is kept up-to-date with the latest available information.

Last updated: July 26, 2026